Zydus Lifesciences and MSN Labs launch US generic Riociguat (Bayer’s Adempas) for PAH and CTEPH, first-to-market.

In an unsurprising move, comedian Jimmy Kimmel has ruthlessly torn into Donald Trump and his recent commercial, which was ...

As commercial marijuana grow operations shut down across Oklahoma, state lawmakers are taking a closer look at what happens ...

Zydus Lifesciences, in collaboration with MSN Laboratories, has launched the first-ever generic version of Bayer's hypertension medication, Adempas (riociguat), in the US market, marking a significant ...

(NASDAQ:MVIS), a leader in advanced perception solutions for industrial, security and defense, and automotive applications, ...

That is truest of all for AI, the technology that dominated last week. It will scale only as far as the energy, data, and trust beneath it allow. In other words, AI's future runs through ...

First-to-market launch brings a lower-cost riociguat to U.S. patients living with pulmonary arterial hypertension and chronic ...

MSN Laboratories developed, manufactured, and received US Food and Drug Administration (FDA) approval for a generic equivalent to Adempas tablets in all five strengths ...